PTI Dec 06, 2019, 01.46 PM IST
New Delhi: Dr Reddy's Laboratories Wednesday said it has launched in the US generic Carboprost Tromethamine injection used for aborting pregnancy. The company has launched Carboprost Tromethamine injection USP, 250 mcg/mL (1mL) single-dose vial in the US market, the pharma major said in a filing to BSE.
The product is a generic version of Pfizer's Hemabate injection in the strength of 250 mcg/mL, it added.
"We are pleased to be first-to-market with this product that has been designated as a Competitive Generic Therapy (CGT) by the FDA," Dr Reddy's Laboratories North America Generics CEO Marc Kikuchi said.
With a CGT designation, the company has 180-day CGT exclusivity to market this product, he added.
As per IQVIA Health data, Hemabate injection, 250 mcg/mL brand had US sales of approximately USD 55 million MAT for the twelve months ended April 2019, Dr Reddy's Labs said.